Highlights from the Gastrointestinal and Genitourinary Cancer Conferences
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Source: curetoday.com
Michiels Van News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michiels Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michiels Van Today - Breaking & Trending Today
Survival Benefits with Keytruda and Padcev in Advanced Urothelial Cancer
Patients with previously untreated locally advanced or metastatic urothelial carcinoma experienced favorable progression-free survival, overall survival and objective response rates when treated with Padcev and Keytruda versus chemotherapy.
Source: curetoday.com
Enfortumab Vedotin Plus Pembrolizumab Maintains Survival Advantage Across Advanced Urothelial Cancer Subgroups
Enfortumab vedotin plus pembrolizumab showed consistent overall survival and progression-free survival benefit in all patients enrolled in EV-302.
Source: onclive.com
Frontline Nivolumab Plus Chemotherapy Boosts OS and PFS in Metastatic Urothelial Carcinoma
Concurrent frontline nivolumab and gemcitabine-cisplatin followed by nivolumab maintenance therapy elicited OS and PFS benefits vs gemcitabine-cisplatin alone in patients with previously untreated, metastatic or unresectable urothelial carcinoma.
Source: onclive.com
Opdivo Plus Chemo Betters Survival in Urothelial Carcinoma
Adding Opdivo to a standard-of-care chemotherapy regimen in patients with unresectable or metastatic urothelial carcinoma improved progression-free and overall survival.
Source: curetoday.com